Probiotics improve lung function in asthma, new meta-analysis finds

If you've ever wondered whether the bacteria in your gut have anything to do with why you keep reaching for your inhaler, a new analysis suggests you're not chasing a fringe idea. Researchers pooling data from randomized trials of adults with asthma found that probiotic supplements measurably improved a standard test of lung function, not just symptoms people reported feeling. The catch: the same trials found no significant improvement in how well people said their asthma was controlled day to day, and the researchers themselves say it's too early to treat probiotics as a real asthma therapy.

Key Takeaways

• A meta-analysis of randomized controlled trials (RCTs, the gold-standard study design where participants are randomly assigned to treatment or placebo) found that multi-strain probiotics improved FEV1, a standard breathing-capacity measurement, in adults with asthma, with a statistically significant result (p=0.02).
• Despite better lung-function numbers, participants' Asthma Control Test (ACT) symptom scores, the day-to-day measure of wheezing, flare-ups, and breathlessness, did not significantly improve.
• The evidence is rated low-to-moderate certainty (using the GRADE framework, the standard scale researchers use to rate how much confidence a body of evidence deserves), and only 7 of 13 identified trials had usable numeric data.
• No severe adverse events were reported, but the study's own authors conclude this does not yet justify adding probiotics to routine asthma treatment.

Multi-Strain Probiotics Boost Lung Function in Asthma

Adults with asthma who took multi-strain probiotics, most combining several Bifidobacterium and Lactobacillus strains, showed a meaningful improvement in FEV1 (forced expiratory volume in one second, essentially how much air you can forcefully blow out in a single breath, a core measure doctors use to gauge lung capacity). The pooled analysis found a standardized mean difference (SMD, a statistical way of comparing effect sizes across trials that measured things slightly differently) of 0.71, a result unlikely to be due to chance (p=0.02). A related measure, FEV1 percent-predicted (your actual FEV1 compared with what's expected for someone of your age, sex, and height), also improved, with an SMD of 0.51 (p=0.026). The systematic review and meta-analysis, published in Frontiers in Immunology in 2026 by Q. Zhang and colleagues, is one of the more rigorous attempts yet to answer a question that's circulated in gut-health circles for years: does feeding the gut microbiome actually change how well your lungs work.

Asthma Affects 23 Million US Adults Who Still Struggle

Asthma is not a rare or niche condition. In the United States alone, 23 million adults, about 8.9% of the adult population, currently live with it, according to CDC survey data. Many manage reasonably well on inhaled corticosteroids and bronchodilators, but a substantial share still cycle through flare-ups, emergency visits, and medications that come with their own side effects. For that population, any credible new lever, especially one as low-risk and accessible as a supplement, is worth taking seriously. The idea draws on the gut-lung axis, the increasingly well-documented communication network between gut bacteria and immune activity in the lungs, which researchers think helps explain why gut microbiome composition seems to track with airway inflammation.

Seven Randomized Trials Anchor the Pooled Analysis

The researchers started broad and narrowed carefully: they identified 13 relevant RCTs testing probiotics, prebiotics (fibers that feed beneficial gut bacteria), or synbiotics (combinations of both) in adults specifically diagnosed with bronchial asthma, then pooled the 7 trials that had numeric data suitable for statistical combination. Restricting the headline FEV1 findings to trials with comparable, extractable data, rather than lumping in every study regardless of quality, is what gives the 0.71 and 0.51 SMD results their credibility. It also explains the modest sample: this is a meta-analysis built on a genuinely small evidence base, not a single massive trial, which is part of why the authors rated overall certainty low-to-moderate under the GRADE framework.

What Adults With Asthma Should Ask Their Doctor

If you have asthma and you're intrigued by this, the honest answer is: raise it with your doctor as a conversation, not a prescription. Nothing here suggests probiotics should replace inhaled corticosteroids, biologics, or any other established asthma treatment, and the study's own authors stop well short of recommending probiotics as routine care. What is worth asking about is whether a probiotic supplement makes sense as something added alongside your existing treatment plan, particularly since the pooled trials reported no severe adverse events. This research is most relevant to adults with diagnosed asthma who are already working with a clinician, not a general audience looking for a preventive gut-health hack, and it says nothing about children, other respiratory conditions, or asthma prevention in people who don't yet have it.

Why Symptom Scores Didn't Improve Is Still Unclear

Here's the part that keeps this from being an easy win: better FEV1 numbers didn't translate into people feeling meaningfully better day to day. ACT scores, which capture things like nighttime symptoms, rescue-inhaler use, and self-rated control, showed no statistically significant change across the pooled trials. That disconnect, an objective breathing-capacity test improving while subjective symptom reports don't, is a genuine open question the study doesn't resolve. It could mean the effect is real but too small to notice subjectively, that ACT scores are a blunter instrument than spirometry, or that something else is going on entirely. The researchers don't claim to know which.

Larger Trials Needed Before Probiotics Become Routine Care

The study's authors are explicit that their own findings shouldn't be read as a green light: this doesn't yet justify probiotics as a routine part of asthma treatment. What comes next, per the paper, is more and larger RCTs with standardized probiotic strains, dosing, and outcome measures, so that future meta-analyses aren't limited to pooling just 7 of 13 available trials. No rollout timeline or specific follow-up trial is named in the study; the authors frame this as a call for the field to build a stronger evidence base before probiotics get anywhere near a treatment guideline.

Common Questions

Does this study mean probiotics can treat asthma?

No. The researchers found a real, statistically significant improvement in a lung-function test, but they explicitly say this isn't yet enough evidence to justify probiotics as a routine asthma treatment, and symptom-control scores didn't improve.

What strains of probiotics were used in these trials?

The trials in the analysis primarily tested multi-strain combinations of Bifidobacterium and Lactobacillus, either as probiotics alone, prebiotics, or synbiotics (a combination of both), though the review doesn't single out one specific strain as most effective.

Is it safe for someone with asthma to try a probiotic supplement?

Across the pooled trials, no severe adverse events were reported, but this study didn't set out to evaluate long-term safety, so anyone with asthma considering a supplement should talk to their doctor first, especially about how it might interact with existing treatment.

Why did lung function improve but not symptoms?

That's an open question the study raises rather than answers. One possibility is that the FEV1 improvement is real but too subtle for people to notice in daily life, but the researchers don't identify a confirmed explanation.

References

1. Qianqian Zhang, Nianzhi Zhang, Ying Zheng, Jing Zhou, Ling Liu, Gang Dong (2026). Effects of probiotics, prebiotics, and synbiotics on lung function and symptoms in adults with bronchial asthma: a systematic review and meta-analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1896757
2. CDC Asthma Data for US Adults. cdc.gov. https://www.cdc.gov/asthma-data/about/most-recent-asthma-data.html